Morales Mallory's Form 4 filing
Immuneering Corp (IMRX) · filed Mar 25, 2024
- Accession no.
- 0001790340-24-000038
- Filed
- Mar 25, 2024
- Trade date
- Mar 15-22, 2024
- Filing delay
- 10 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $4.01K. It was filed 10 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Morales MalloryCIK 0001941795 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Class A Common Stock | AGrant or awardAcquired | +4,344 | $1.62 | +$7,037.28 | 6,778 | Direct | |
| Mar 21, 2024 | Class A Common Stock | PPurchaseAcquired | +1,107 | $2.72 | +$3,011.04 | 7,885 | Direct | |
| Mar 22, 2024 | Class A Common Stock | PPurchaseAcquired | +393 | $2.55 | +$1,002.15 | 8,278 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.